Loading…
HIV protease inhibitors induce metabolic dysfunction in part via increased JNK1/2 pro-inflammatory signaling in L6 cells
► Atazanavir sulfate+ritonavir treatment increases glucose and fatty acid metabolism. ► Atazanavir sulfate+ritonavir treatment induces a pro-inflammatory state. ► The protease inhibitor-induced pro-inflammatory state induces insulin resistance. Protease inhibitors (PIs), such as atazanavir sulfate a...
Saved in:
Published in: | Antiviral research 2011-12, Vol.92 (3), p.415-423 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | ► Atazanavir sulfate+ritonavir treatment increases glucose and fatty acid metabolism. ► Atazanavir sulfate+ritonavir treatment induces a pro-inflammatory state. ► The protease inhibitor-induced pro-inflammatory state induces insulin resistance.
Protease inhibitors (PIs), such as atazanavir sulfate and ritonavir, are used clinically to prevent the progression of HIV and are known to induce insulin resistance. To determine whether PI-mediated insulin resistance is induced by activation of pro-inflammatory cascades, L6 skeletal muscle cells were treated ±atazanavir sulfate, ritonavir, or atazanavir sulfate+ritonavir, and ±insulin. Treatment with atazanavir sulfate, ritonavir, or atazanavir sulfate+ritonavir for 24 or 48h significantly increased basal glucose uptake (P |
---|---|
ISSN: | 0166-3542 1872-9096 |
DOI: | 10.1016/j.antiviral.2011.09.008 |